They deduce that miR-602/RASSF1A may be an early diagnostic sign mediated by HBV because it has been documented that miR-602 can play a cancer-promoting function in the incidence of HBV-related liver cancer through consistent RASSF1A [22]. Here, RASSF1 is linked to liver cancer.